Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

… , 2016 /PRNewswire/ -- Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to … the Market
Summary
Non-Small Cell Lung Cancer (NSCLC) is the most common … 1.8 million newly diagnosed lung cancer cases in 2012 globally, accounting … to increase, the prevalence of lung cancer is anticipated to increase, thereby …